Recherche - Archive ouverte HAL Accéder directement au contenu

Filtrer vos résultats

4 Résultats
authFullName_s : S. Manfredi

609TiPPRODIGE 50 - ASPIK French: French double blind randomised study of aspirin versus placebo in resected stage III or high risk stage II colon cancer with PIK3CA mutation

P. Michel , T. André , V. Boige , T. Aparicio , E. Maillard et al.
the 42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid, Spain. ⟨10.1093/annonc/mdx393.134⟩
Communication dans un congrès hal-01632463v1

PO-0702: Phase I trial evaluating panitumumab in combination with chemoradiotherapy for anal cancers

V. Vendrely , C. Lemanski , E. Le Prise , E. Maillard , X. Mirabel et al.
ESTRO 36, May 2017, Vienne, Austria. , Radiotherapy and Oncology, 123 (Supplement 1), pp.S367 - S368, 2017, ESTRO 36, May 5-9, 2017, Vienna, Austria. ⟨10.1016/S0167-8140(17)31139-8⟩
Poster de conférence hal-01685153v1

773TiPPRODIGE 51 - GASTFOX: Phase III randomised trial evaluating FOLFOX with or without DOCETAXEL (TFOX) as 1st line chemotherapy for locally advanced or metastatic oesophago-gastric adenocarcinoma

A. Zaanan , E. Samalin , C. Louvet , C. Montérymard , F. Khemissa et al.
the 42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid, Spain. ⟨10.1093/annonc/mdx369.155⟩
Communication dans un congrès hal-01632489v1

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort

T. Walter , T Tougeron , Emmanuel Baudin , K. Le Malicot , T. Lecomte et al.
European Journal of Cancer, 2017, 79, pp.158 - 165. ⟨10.1016/j.ejca.2017.04.009⟩
Article dans une revue hal-01609152v1